Terumo
Terumo is a prominent global medical technology company headquartered in Tokyo, with a workforce of over 25,000 employees serving clients in more than 160 countries. Founded nearly a century ago as a thermometer manufacturer, Terumo has evolved to offer a wide range of innovative medical solutions. Its business is divided into three main segments: blood management, cardiac and vascular, and general hospital products. The cardiac and vascular division is the largest revenue generator, providing therapies for cardiac and endovascular interventions, surgical systems, and neurovascular products. The general hospital segment includes diabetes management and essential medical products, while the blood management division focuses on blood component technologies and therapeutic apheresis. Committed to contributing to society through healthcare, Terumo aims to deliver value to patients and healthcare professionals alike.
Founded in 2007, Sequent Medical, Inc. is a privately-held venture backed medical device company dedicated to the development of innovative catheter-based neurovascular technologies. The company has invented and developed the proprietary Microbraid™ technology to create the WEB™ Aneurysm Embolization System, a compelling and versatile new option for the treatment of both ruptured and unruptured aneurysms. The WEB has received the CE mark and to date has been used to treat a wide variety of nearly 600 aneurysms in Europe, Latin America and New Zealand. The WEB is not available for sale or use in the United States.
Sequent Medical, Inc. is headquartered in Aliso Viejo, California and has European operations based in Bonn, Germany.
MicroVention Terumo is a medical device company specializing in catheter-based and minimally-invasive technologies for treating cerebral aneurysms and other neurovascular conditions. Founded in 1997 and headquartered in Tustin, California, the company develops a range of products, including delivery and detachment systems, access products, intraluminal devices, occlusion balloons, and flow diverters. Its notable technologies include the HydroCoil Embolic System, which utilizes platinum micro-coil technology for endovascular embolization, and the MicroPlex Coil System, designed for various aneurysm morphologies. MicroVention Terumo distributes its products through a network of specialty distributors across North America, South America, Europe, Africa, the Middle East, and Asia Pacific. The company has been operating as a subsidiary of Terumo Corporation since 2006.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.